Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib
文献类型：期刊论文
| 作者 | Ren, Xiaomei ; Pan, Xiaofen ; Zhang, Zhang ; Wang, Deping ; Lu, Xiaoyun ; Li, Yupeng ; Wen, Donghai ; Long, Huoyou ; Luo, Jinfeng ; Feng, Yubing ; Zhuang, Xiaoxi ; Zhang, Fengxiang ; Liu, Jianqi ; Leng, Fang ; Lang, Xingfen ; Bai, Yang ; She, Miaoqin ; Tu, Zhengchao ; Pan, Jingxuan ; Ding, Ke |
| 刊名 | JOURNAL OF MEDICINAL CHEMISTRY
 |
| 出版日期 | 2013 |
| 卷号 | 56期号:3 |
| ISSN号 | 0022-2623 |
| 学科主题 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| 公开日期 | 2016-12-16 |
| 源URL | [http://ir.gibh.ac.cn/handle/344009/764]  |
| 专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
| 推荐引用方式 GB/T 7714 | Ren, Xiaomei,Pan, Xiaofen,Zhang, Zhang,et al. Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib[J]. JOURNAL OF MEDICINAL CHEMISTRY,2013,56(3). |
| APA | Ren, Xiaomei.,Pan, Xiaofen.,Zhang, Zhang.,Wang, Deping.,Lu, Xiaoyun.,...&Ding, Ke.(2013).Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib.JOURNAL OF MEDICINAL CHEMISTRY,56(3). |
| MLA | Ren, Xiaomei,et al."Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib".JOURNAL OF MEDICINAL CHEMISTRY 56.3(2013). |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。